|
ATG4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.85247389544929E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67121871896825E-12 |
| Normal-vs-Stage2 |
3.67730000000455E-05 |
| Normal-vs-Stage3 |
3.56449999960873E-07 |
| Normal-vs-Stage4 |
3.23350002329192E-09 |
| Stage1-vs-Stage2 |
9.663800E-01 |
| Stage1-vs-Stage3 |
7.922400E-01 |
| Stage1-vs-Stage4 |
9.793800E-02 |
| Stage2-vs-Stage3 |
8.323000E-01 |
| Stage2-vs-Stage4 |
2.011000E-01 |
| Stage3-vs-Stage4 |
1.074390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62925228863742E-12 |
| Normal-vs-AfricanAmerican |
2.15789999979954E-07 |
| Normal-vs-Asian |
2.536400E-01 |
| Caucasian-vs-AfricanAmerican |
7.274400E-02 |
| Caucasian-vs-Asian |
4.790000E-02 |
| AfricanAmerican-vs-Asian |
4.098000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4432899320127E-15 |
| Normal-vs-Female |
6.53470000000489E-07 |
| Male-vs-Female |
1.704660E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.06119999968513E-07 |
| Normal-vs-Extreme_Weight |
1.62680979798324E-12 |
| Normal-vs-Obese |
6.90292267790937E-12 |
| Normal-vs-Extreme_Obese |
1.262190E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.921600E-01 |
| Normal_Weight-vs-Obese |
8.719800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.861400E-01 |
| Extreme_Weight-vs-Obese |
3.073200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.847000E-01 |
| Obese-vs-Extreme_Obese |
6.231400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.58549999965219E-07 |
| Normal-vs-Age(41-60Yrs) |
9.98534588347866E-13 |
| Normal-vs-Age(61-80Yrs) |
7.32747196252603E-15 |
| Normal-vs-Age(81-100Yrs) |
1.50890000494286E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.392600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.588600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.918980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.955800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.747200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.823400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.83989999902323E-08 |
| Normal-VS-KIRP CIMP |
2.29419999997482E-07 |
| Normal-VS-Unclassified PRCC |
1.83350001847771E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.332990E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.300600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.202600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.108400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.404800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.258600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.14229958825263E-10 |
| Normal-vs-N1 |
3.50997009235243E-12 |
| Normal-vs-N2 |
2.202600E-04 |
| N0-vs-N1 |
2.823400E-01 |
| N0-vs-N2 |
7.364200E-01 |
| N1-vs-N2 |
8.665000E-01 |
|
|
